SG11202107690SA - Methods, uses & compositions - Google Patents
Methods, uses & compositionsInfo
- Publication number
- SG11202107690SA SG11202107690SA SG11202107690SA SG11202107690SA SG11202107690SA SG 11202107690S A SG11202107690S A SG 11202107690SA SG 11202107690S A SG11202107690S A SG 11202107690SA SG 11202107690S A SG11202107690S A SG 11202107690SA SG 11202107690S A SG11202107690S A SG 11202107690SA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00041—Use of virus, viral particle or viral elements as a vector
- C12N2795/00042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1901099.0A GB201901099D0 (en) | 2019-01-27 | 2019-01-27 | Methods, uses and compositions |
PCT/EP2020/051937 WO2020152369A1 (en) | 2019-01-27 | 2020-01-27 | Methods, uses & compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202107690SA true SG11202107690SA (en) | 2021-08-30 |
Family
ID=65656096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202107690SA SG11202107690SA (en) | 2019-01-27 | 2020-01-27 | Methods, uses & compositions |
Country Status (8)
Country | Link |
---|---|
US (1) | US20220162270A1 (en) |
EP (1) | EP3914607A1 (en) |
JP (1) | JP2022523043A (en) |
CN (1) | CN113677695A (en) |
GB (1) | GB201901099D0 (en) |
IL (1) | IL284800A (en) |
SG (1) | SG11202107690SA (en) |
WO (1) | WO2020152369A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL283877B (en) | 2015-05-06 | 2022-07-01 | Snipr Tech Ltd | Altering microbial populations & modifying microbiota |
GB201609811D0 (en) | 2016-06-05 | 2016-07-20 | Snipr Technologies Ltd | Methods, cells, systems, arrays, RNA and kits |
US10760075B2 (en) | 2018-04-30 | 2020-09-01 | Snipr Biome Aps | Treating and preventing microbial infections |
IL308147A (en) * | 2021-05-12 | 2023-12-01 | Eligo Bioscience | Production bacterial cells and use thereof in production methods |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU699322B2 (en) | 1994-04-05 | 1998-12-03 | Exponential Biotherapies, Inc. | Antibacterial therapy with genotypically modified bacteriophage |
US20020044922A1 (en) | 1996-02-06 | 2002-04-18 | Sven Mardh | Recombinant phages |
WO2000069269A1 (en) | 1999-05-13 | 2000-11-23 | Exponential Biotherapies, Inc. | Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
US20020001590A1 (en) | 2000-04-20 | 2002-01-03 | Mount Sinai Hospital | Antibacterial therapy for multi-drug resistant bacteria |
WO2001090331A2 (en) | 2000-05-23 | 2001-11-29 | The Rockefeller University | C1 bacteriophage lytic system |
US20020013270A1 (en) | 2000-06-05 | 2002-01-31 | Bolte Ellen R. | Method for treating a mental disorder |
EP1305038B1 (en) | 2000-07-25 | 2005-10-05 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Bacteriophage having multiple host range |
KR20200029627A (en) | 2014-03-12 | 2020-03-18 | 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 | Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns |
IL283877B (en) | 2015-05-06 | 2022-07-01 | Snipr Tech Ltd | Altering microbial populations & modifying microbiota |
-
2019
- 2019-01-27 GB GBGB1901099.0A patent/GB201901099D0/en not_active Ceased
-
2020
- 2020-01-27 JP JP2021543156A patent/JP2022523043A/en active Pending
- 2020-01-27 SG SG11202107690SA patent/SG11202107690SA/en unknown
- 2020-01-27 WO PCT/EP2020/051937 patent/WO2020152369A1/en unknown
- 2020-01-27 CN CN202080024158.6A patent/CN113677695A/en active Pending
- 2020-01-27 US US17/310,205 patent/US20220162270A1/en active Pending
- 2020-01-27 EP EP20702442.3A patent/EP3914607A1/en active Pending
-
2021
- 2021-07-12 IL IL284800A patent/IL284800A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2022523043A (en) | 2022-04-21 |
IL284800A (en) | 2021-08-31 |
CN113677695A (en) | 2021-11-19 |
US20220162270A1 (en) | 2022-05-26 |
EP3914607A1 (en) | 2021-12-01 |
WO2020152369A1 (en) | 2020-07-30 |
GB201901099D0 (en) | 2019-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3665156A4 (en) | Compounds, compositions and methods | |
IL285302A (en) | Compounds, compositions and methods | |
EP3676297A4 (en) | Compounds, compositions and methods | |
EP3924341A4 (en) | Compounds, compositions and methods | |
GB201916960D0 (en) | Compositions | |
IL284800A (en) | Methods, uses & compositions | |
GB201903287D0 (en) | Composition | |
SG11202108460VA (en) | Compositions | |
GB202017595D0 (en) | Compositions, and methods and uses relating thereto | |
GB201913593D0 (en) | Composition | |
IL287120A (en) | Compounds, compositions and methods | |
GB2576614B (en) | Compositions, uses and methods | |
IL289125A (en) | Compositions | |
GB201804163D0 (en) | Uses, compositions and methods | |
GB201908396D0 (en) | Compositions | |
GB201912061D0 (en) | Composition | |
IL285046A (en) | Anti-apicomplexan compositions | |
GB201919234D0 (en) | Compositions | |
GB201911694D0 (en) | Composition | |
GB201911454D0 (en) | Composition | |
GB201907225D0 (en) | Composition | |
GB201903340D0 (en) | Composition | |
EP3625234A4 (en) | Compounds, compositions and methods | |
GB202004020D0 (en) | Methods, uses & compositions | |
GB201905218D0 (en) | Eletrode compositions |